Company · CIK 0001528115 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Annexon, Inc. · ANNX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 PForm 4 → | Sep 25, 4:15 pm EDT | Douglas LovePRESIDENT AND CEO, Director | 26,065 | $3.83 | $99,829 | 390,476 | +7.15% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 AForm 4 → | Aug 12, 6:10 pm EDT | Mark S. BlumenkranzDirector | 175,000 | — | — | 175,000 | — |